Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Haemonetics: Solid Performance Of This Blood Play
06:15am, Wednesday, 22'nd Nov 2023
Haemonetics has seen signs of growth and operational momentum after a challenging period during the pandemic. The company's fiscal year 2024 first half results were solid, increasing its appeal. Still
HAE or SYK: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 15'th Nov 2023
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Stryker (SYK). But which of these two companies is the best option for those looking fo
Is Haemonetics (HAE) a Solid Growth Stock? 3 Reasons to Think "Yes"
02:17pm, Friday, 10'th Nov 2023
Haemonetics (HAE) could produce exceptional returns because of its solid growth attributes.
Haemonetics Corporation (HAE) Q2 2024 Earnings Call Transcript
06:21pm, Friday, 03'rd Nov 2023
Haemonetics Corporation (NYSE:HAE ) Q2 2024 Earnings Conference Call November 2, 2023 8:00 AM ET Company Participants Olga Guyette – Senior Director, Investor Relations and Treasury Chris Simon –
Haemonetics (HAE) Q2 Earnings Top Estimates, 2024 View Up
12:02pm, Friday, 03'rd Nov 2023
The robust volume growth and price benefits in the Plasma business driven by strong momentum in U.S. collections and price benefit Haemonetics' (HAE) fiscal second-quarter results.
Haemonetics (HAE) is an Incredible Growth Stock: 3 Reasons Why
02:17pm, Friday, 20'th Oct 2023
Haemonetics (HAE) could produce exceptional returns because of its solid growth attributes.
Here's Why You Should Invest in Haemonetics (HAE) Right Now
01:32pm, Thursday, 19'th Oct 2023
Investors are optimistic about Haemonetics (HAE) on robust volume growth in the Plasma business and upbeat guidance.
5 Medical Product Stocks to Buy Amid Industry Recovery
09:46am, Thursday, 12'th Oct 2023
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, BSX, ZBH, PODD and HAE are well-pois
Haemonetics (HAE) Moves to Strong Buy: Rationale Behind the Upgrade
01:32pm, Wednesday, 11'th Oct 2023
Haemonetics (HAE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Haemonetics (HAE) Announces Agreement to Acquire OpSens
12:47pm, Wednesday, 11'th Oct 2023
Haemonetics' (HAE) acquisition of OpSens will expand its leadership in the interventional cardiology market.
Opsens stock soars on takeover deal with Haemonetics
12:24pm, Tuesday, 10'th Oct 2023
Opsens Inc shares surged 47% to $2.84 in midday trading on Tuesday after the cardiology-focused medical device company agreed to be acquired by global healthcare firm Haemonetics Corporation for C$
Is Haemonetics (HAE) Stock Outpacing Its Medical Peers This Year?
11:17am, Wednesday, 04'th Oct 2023
Here is how Haemonetics (HAE) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.
HAE vs. SYK: Which Stock Is the Better Value Option?
12:46pm, Monday, 25'th Sep 2023
Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
3 Reasons Growth Investors Will Love Haemonetics (HAE)
02:17pm, Wednesday, 06'th Sep 2023
Haemonetics (HAE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Medical Stocks Lagging Haemonetics (HAE) This Year?
11:17am, Friday, 01'st Sep 2023
Here is how Haemonetics (HAE) and Ayr Wellness Inc. (AYRWF) have performed compared to their sector so far this year.
